HomeCiprofloxacinCiprofloxacin + Pirfenidone Capsule 267 Mg

Does Ciprofloxacin Interact with Pirfenidone Capsule 267 Mg?

Ciprofloxacin and Pirfenidone Capsule 267 Mg have a moderate drug interaction according to U.S. FDA drug labeling data. 7 DRUG INTERACTIONS Moderate (e.g., ciprofloxacin) and strong inhibitors of CYP1A2 (e.g., fluvoxamine) increase systemic exposure of pirfenidone and may alter the adverse reaction profile of pirfenidone. Consider dosage reduction with use of ciprofloxacin. Moderate CYP1A2 Inhibitors Concomitant administration of pirfenidone and ciprofloxacin (a moderate inhibitor of CYP1A2) moderately increases exposure to pirfenidone [see Clinical Pharmacology ( 12.3 )] . Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ciprofloxacin Class
Fluoroquinolone Antibacterial
Pirfenidone Capsule 267 Mg Class
Pyridone
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Ciprofloxacin and your doctor is considering prescribing Pirfenidone Capsule 267 Mg (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ciprofloxacin(Otovel)+💊 Pirfenidone Capsule 267 Mg(Esbriet)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Fluoroquinolone Antibacterial
Drug B class
Pyridone
Source
FDA drug label - pirfenidone capsule, 267 mg

What this means in plain English

7 DRUG INTERACTIONS Moderate (e.g., ciprofloxacin) and strong inhibitors of CYP1A2 (e.g., fluvoxamine) increase systemic exposure of pirfenidone and may alter the adverse reaction profile of pirfenidone. Consider dosage reduction with use of ciprofloxacin. Moderate CYP1A2 Inhibitors Concomitant administration of pirfenidone and ciprofloxacin (a moderate inhibitor of CYP1A2) moderately increases exposure to pirfenidone [see Clinical Pharmacology ( 12.3 )] .

About Ciprofloxacin and Pirfenidone Capsule 267 Mg

Ciprofloxacin is a Fluoroquinolone Antibacterial, while Pirfenidone Capsule 267 Mg is a Pyridone. You may recognize them by the brand names Otovel and Esbriet. Both medications are taken by mouth. Ciprofloxacin additionally carries an FDA boxed warning, the FDA's strongest safety alert.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ciprofloxacin and Pirfenidone Capsule 267 Mg against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.